On Oct 31, major Wall Street analysts update their ratings for $Bausch + Lomb Corp. (BLCO.US)$, with price targets ranging from $23 to $26.
Citi analyst Joanne Wuensch maintains with a buy rating, and sets the target price at $24.
Wells Fargo analyst Larry Biegelsen maintains with a buy rating, and adjusts the target price from $23 to $26.
Needham analyst David Saxon maintains with a hold rating.
RBC Capital analyst Douglas Miehm maintains with a buy rating, and maintains the target price at $23.
H.C. Wainwright analyst Yi Chen maintains with a buy rating, and adjusts the target price from $22 to $23.
Furthermore, according to the comprehensive report, the opinions of $Bausch + Lomb Corp. (BLCO.US)$'s main analysts recently are as follows:
The company has been recognized for delivering a solid quarter with little to criticize. Executing on its vision, the company is still in the early stages of growth, and it has chosen to forgo some immediate margin expansion as it continues to invest in key growth drivers of the business.
The company's Q3 sales and EBITDA surpassed expectations, and there has been an upward revision of guidance for both metrics. There is anticipation of continued positive momentum into Q4 and beyond, driven by most of the company's segments, robust Miebo uptake, and improvements in Xiidra.
Here are the latest investment ratings and price targets for $Bausch + Lomb Corp. (BLCO.US)$ from 5 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美东时间10月31日，多家华尔街大行更新了$博士伦 (BLCO.US)$的评级，目标价介于23美元至26美元。
花旗分析师Joanne Wuensch维持买入评级，目标价24美元。
富国集团分析师Larry Biegelsen维持买入评级，并将目标价从23美元上调至26美元。
Needham分析师David Saxon维持持有评级。
加皇资本市场分析师Douglas Miehm维持买入评级，维持目标价23美元。
H.C. Wainwright分析师Yi Chen维持买入评级，并将目标价从22美元上调至23美元。
此外，综合报道，$博士伦 (BLCO.US)$近期主要分析师观点如下：
以下为今日5位分析师对$博士伦 (BLCO.US)$的最新投资评级及目标价：
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
